Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.

Leukemia · 2023 · PMC9883149 · PMID 36309560

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although a direct comparison of the outcome of patients with MEF2D::HNRNPUL1 or MEF2D::BCL9 did not reach statistical significance, the large numerical differences in relapse and EFS do indicate outcome heterogeneity according to partner gene.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.